Investor Overview

Webcast ImageWebcast
Xenon Pharmaceuticals Corporate Update (Replay)
April 26, 2017 at 6:00 a.m. PT
Xenon Pharmaceuticals Corporate Update
Wednesday, April 26, 2017 6:00 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Xenon Pharmaceuticals Inc at the 2017 Bloom Burton & Co. Healthcare Investor Conference  (Live)
May 2, 2017 at 11:00 a.m. ET
Xenon Pharmaceuticals Inc at the 2017 Bloom Burton & Co. Healthcare Investor Conference
Tuesday, May 2, 2017 11:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Company Profile
We are a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications that we intend to commercialize on our own, and for larger market indications that we intend to partner with global pharmaceutical industry leaders. We have built a core platform, which we call Extreme Genetics®, enabling the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. Our integrated platform has a full complement of in-house capabilities for human genetics and small molecule drug discovery, and for pre-clinical and clinical development.
Stock Quote
XENE (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$3.95
Change (%) Stock is Down 0.15 (3.66%)
Volume36,272
Data as of April 28, 2017 3:59 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent Press ReleasesMore >>
April 28, 2017 – 4:03 p.m.
Xenon Pharmaceuticals to Present at the 2017 Bloom Burton & Co. Healthcare Investor Conference
Upcoming EventsMore >>
Tuesday, May 2, 2017 11:00 a.m. ET
Xenon Pharmaceuticals Inc at the 2017 Bloom Burton & Co. Healthcare Investor Conference

Thursday, June 1, 2017 11:30 a.m. PT
Xenon Pharmaceuticals Inc Annual Meeting of Shareholders
Supporting Materials
Download Event Supporting Material Notice of Meeting
Download Event Supporting Material Information Circular
Download Event Supporting Material Form of Proxy

What's New
Download Documentation 2016 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Xenon Pharmaceuticals Inc posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources